Preferred Label : ECOG Performance Status 5;

NCIt synonyms : ECOG 5;

NCIt related terms : 5;

NCIt definition : Dead.;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3496700/fr/omnipod-5-pompe-a-insuline-et-controleur-omnipod-5-systeme-de-mesure-du-glucose-interstitiel-dexcom-g6
2024
France
health technology assessment
Mercaptopurine/Methotrexate/Methylprednisolone/Vincristine
weights and measures
System of Measurement
Pump Device
Upset Score 5
Insulin Measurement
insulin pump, nos
Glucose Measurement
Type 1 Diabetes Mellitus
diabetes mellitus, type 1
Insulin
Pump
Intensity and Distress 5
Illness Intrusiveness Rating 5
Cryptogenic Organizing Pneumonia
glucose
Management Occupations
Management
robot
State Machine
Phase V Trial
glucose, nos
Severity of Symptom Score 5
insulin infusion systems
Mercaptopurine/Methotrexate/Prednisolone/Vincristine
Neck Pain Score 5
Fear Score 5
Current Reformed Smoker, Years Unknown
glucose
Controller Device
ECOG Performance Status 5
Thought Score 5
Automatic
measures
Gleason Grade Group 5
automatism
Interstitial Route of Administration
Anemia of Prematurity
Agreement Score 5
Death Related to Adverse Event
Therapeutic Insulin
Loss of Chromosome 5
automatism
Epirubicin/Prednisone/Vincristine
Clinical Status Ordinal Scale Outcome 5

---
https://www.has-sante.fr/jcms/p_3508871/fr/icesphere-1-5-cx-90
2024
France
health technology assessment
Neck Pain Score 1
One Hundred Percent
Never Smoker
Agreement Score 5
Severity of Symptom Score 1
Gleason Grade Group 1
ECOG Performance Status 1
Thought Score 5
Intensity and Distress 5
needles
Fear Score 5
Severity of Symptom Score 5
Symptoms Extent Score 1
Lansky Performance Status 90
Gleason Grade Group 5
One Full Term Pregnancy
CDISC SDTM Model Version 1.6
CDISC SDTM Model Version 1.5
Tumor Regression Score 1
Christmas Island
Illness Intrusiveness Rating 1
Loss of Chromosome 5
Capecitabine/Cisplatin Regimen
Clinical Status Ordinal Scale Outcome 1
Nebulizer Solution Dosage Form
Agreement Score 1
Phase V Trial
Cryosurgery
Fear Score 1
Clinical Status Ordinal Scale Outcome 5
Mild Adverse Event
Thought Score 1
Current Reformed Smoker, Years Unknown
Cryoablation for Arrhythmia
Upset Score 1
Karnofsky Performance Status 90
Solomon Islands
One
Cryoablation
1+ Score
Neck Pain Score 5
Death Related to Adverse Event
ECOG Performance Status 5
Phase I Trial
cryosurgery
needle
1+ Score, WHO
Illness Intrusiveness Rating 5
Ninety
Intensity and Distress 1
railway signalman
Nebulizer Solution Dosage Form
Upset Score 5

---
https://publications.msss.gouv.qc.ca/msss/document-003688/
2024
Canada
scientific and technical information
Fear Score 5
suicide
Upset Score 5
suicide, nos
ECOG Performance Status 5
Autonomic Nervous System
Thought Score 5
Severity of Symptom Score 5
Intensity and Distress 5
Suicide
Thirteen
Agreement Score 5
Loss of Chromosome 5
cues
Clinical Status Ordinal Scale Outcome 5
attentiveness
Phase V Trial
Death Related to Adverse Event
Child
Gleason Grade Group 5
Offspring
Illness Intrusiveness Rating 5
Current Reformed Smoker, Years Unknown
child
business
commerce
child, nos
Neck Pain Score 5

---
https://www.has-sante.fr/jcms/p_3508889/fr/icerod-1-5-cx-90-et-icerod-1-5-mri-90
2024
France
health technology assessment
Tumor Regression Score 1
Gleason Grade Group 1
Mild Adverse Event
One
cryosurgery
Fear Score 5
Clinical Status Ordinal Scale Outcome 5
1+ Score, WHO
Cryoablation for Arrhythmia
Cryoablation
Clinical Status Ordinal Scale Outcome 1
railway signalman
Intensity and Distress 1
Upset Score 5
Thought Score 5
Intensity and Distress 5
ECOG Performance Status 5
Phase V Trial
CDISC SDTM Model Version 1.5
Thought Score 1
Ninety
Neck Pain Score 1
Phase I Trial
Fear Score 1
Nebulizer Solution Dosage Form
Christmas Island
Severity of Symptom Score 1
Neck Pain Score 5
One Full Term Pregnancy
Never Smoker
ECOG Performance Status 1
Symptoms Extent Score 1
Illness Intrusiveness Rating 5
1+ Score
needles
Current Reformed Smoker, Years Unknown
Cryosurgery
Nebulizer Solution Dosage Form
Lansky Performance Status 90
Death Related to Adverse Event
One Hundred Percent
Severity of Symptom Score 5
Agreement Score 5
Solomon Islands
Agreement Score 1
Karnofsky Performance Status 90
magnetic resonance imaging
Upset Score 1
Gleason Grade Group 5
needle
Capecitabine/Cisplatin Regimen
CDISC SDTM Model Version 1.6
Loss of Chromosome 5
Illness Intrusiveness Rating 1

---
https://campus.neurochirurgie.fr/article1724.html
2023
France
educational course
central nervous system
Clinical Status Ordinal Scale Outcome 5
central nervous system
Primary Central Nervous System Lymphoma
Upset Score 5
Cerebral Lymphoma
Intensity and Distress 5
malignant lymphoma, nos
ECOG Performance Status 5
Severity of Symptom Score 5
Current Reformed Smoker, Years Unknown
Fear Score 5
Agreement Score 5
Loss of Chromosome 5
Phase V Trial
lymphoma
Illness Intrusiveness Rating 5
Gleason Grade Group 5
Thought Score 5
Neck Pain Score 5
Death Related to Adverse Event

---
https://www.has-sante.fr/jcms/p_3468959/fr/developpement-de-l-indicateur-sur-la-mesure-de-la-recuperation-de-5-complications-post-operatoires
2023
France
technical report
Maturation
postoperative complication, nos
Upset Score 5
Customize
ECOG Performance Status 5
suggestive of
Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery
Operative
Agreement Score 5
Thought Score 5
Recovery
Measurement
Fear Score 5
Development Batch
postoperative complications
Indicator
Gleason Grade Group 5
Measured Tumor Identification
Complication
Intensity and Distress 5
Neck Pain Score 5
Death Related to Adverse Event
Loss of Chromosome 5
Severity of Symptom Score 5
Current Reformed Smoker, Years Unknown
Development Lot
measures
Measurement
Stock Recovery
Alpha-lipoic Acid/Boswellia Serrata Extract/Methylsulfonylmethane/Bromelain Dietary Supplement
Illness Intrusiveness Rating 5
indication of
Phase V Trial
indicators and reagents
Clinical Status Ordinal Scale Outcome 5
weights and measures

---
https://dumas.ccsd.cnrs.fr/dumas-04485360
2023
France
dissertations, academic
Focus
educational status
Shield Device
exposure to
classification
Reasoning
Loss of Chromosome 5
Upset Score 5
Child
education
Thought Score 5
review literature as topic
asthenia
Illness Intrusiveness Rating 5
Systematic Review
Education Level
Intensity and Distress 5
Neck Pain Score 5
shield, nos
Clinical Status Ordinal Scale Outcome 5
Phase V Trial
Reviewing
Severity of Symptom Score 5
Fear Score 5
child, nos
thinking, nos
Autonomic Nervous System
Current Reformed Smoker, Years Unknown
Offspring
child
Low Level
ECOG Performance Status 5
Gleason Grade Group 5
Death Related to Adverse Event
What Month is it
Exposure Domain
Workhouses
Exposure
Agreement Score 5

---
https://www.minerva-ebp.be/FR/Analysis/833
2023
Belgium
critical appraisal or critical reading
Phase V Trial
Thought Score 5
Medication
physicians
ECOG Performance Status 5
Responsive Disease
Loss of Chromosome 5
Comparison
Artificial Intelligence
Fear Score 5
Neck Pain Score 5
Intensity and Distress 5
volunteers
Clinical Status Ordinal Scale Outcome 5
Severity of Symptom Score 5
Agreement Score 5
Public
Questioning
Death Related to Adverse Event
Current Reformed Smoker, Years Unknown
Pet Responds to Presence
Examination Questions
intelligence, nos
Response_Gloss
Upset Score 5
Illness Intrusiveness Rating 5
artificial intelligence
Gleason Grade Group 5

---
https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les
2023
United Kingdom
review of literature
french abstract
Ratio
secondary raynaud's phenomenon
Increased
Current Reformed Smoker, Years Unknown
increased vascular flow
risks and benefits
Fear Score 5
Medication
Placebo
raynaud disease
What Month is it
Loss of Chromosome 5
Intensity and Distress 5
drug, nos
Flow
Extremities
Clinical Status Ordinal Scale Outcome 5
extremities
Version
research report
ECOG Performance Status 5
anthelmintics
Severity of Symptom Score 5
No Flow
Thought Score 5
raynaud phenomenon
Death Related to Adverse Event
Agreement Score 5
Illness Intrusiveness Rating 5
Raynaud Phenomenon
Gleason Grade Group 5
risk assessment
placebos
Phase V Trial
Regulatory Report
Phosphodiesterase Inhibitor
Neck Pain Score 5
phosphodiesterase 5 inhibitors
Upset Score 5
albumin/globulin ratio
Increase
Flux
GDC Therapeutic Agent Terminology

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_2023_24_covid-19_novavax.pdf
2023
France
scientific and technical information
Device
Neck Pain Score 5
vaccination
Never Smoker
Novavax
Fear Score 5
1+ Score
Set, Psychology
ECOG Performance Status 5
Agreement Score 5
Severity of Symptom Score 5
Neck Pain Score 1
Illness Intrusiveness Rating 1
Thought Score 5
Severity of Symptom Score 1
ECOG Performance Status 1
devices
laboratories
One Hundred Percent
Intensity and Distress 1
Illness Intrusiveness Rating 5
Phase I Trial
Thought Score 1
Loss of Chromosome 5
CDISC SDTM Model Version 1.5
One Full Term Pregnancy
rehabilitation
COVID-19 Vaccines
Adaptation
habilitation
Mild Adverse Event
vaccinia
Death Related to Adverse Event
Agreement Score 1
Clinical Status Ordinal Scale Outcome 5
adaptation, nos
Gleason Grade Group 5
COVID-19 Vaccine
Intensity and Distress 5
vaccines
COVID-19
Change
Upset Score 5
Upset Score 1
preventive immunization/medication
Current Reformed Smoker, Years Unknown
Fear Score 1
One
vaccination
Gleason Grade Group 1
CDISC SDTM Model Version 1.6
Phase V Trial
Clinical Status Ordinal Scale Outcome 1
vaccine, nos
1+ Score, WHO
Tumor Regression Score 1
device, nos
Symptoms Extent Score 1

---
https://www.cultures-sante.be/nos-outils/fiches-lisa/item/530-fiche-lisa-n-5-comment-rendre-un-lieu-d-accueil-favorable-a-l-exercice-de-la-litteratie-en-sante.html
2019
Belgium
scientific and technical information
Agreement Score 5
Favorable
Fear Score 5
Gleason Grade Group 5
Exercise Pain Management
Phase V Trial
Severity of Symptom Score 5
Upset Score 5
Before Exercise
Placement
ECOG Performance Status 5
What Month is it
Exercise
Literacy
Clinical Status Ordinal Scale Outcome 5
Loss of Chromosome 5
Current Reformed Smoker, Years Unknown
exercise
Put
Illness Intrusiveness Rating 5
Thought Score 5
Place
Intensity and Distress 5
health literacy
Neck Pain Score 5
Death Related to Adverse Event

---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_version-finale_site-public_20151112.pdf
2015
Canada
drug information
Gleason Grade Group 5
Thought Score 5
Agreement Score 5
Phase V Trial
Death Related to Adverse Event
Use
Severity of Symptom Score 5
myelodysplasia
Illness Intrusiveness Rating 5
Loss of Chromosome 5
Intensity and Distress 5
myelodysplastic syndromes
NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology
Analyzed
Analysis
Adult Myelodysplastic Syndrome
Clinical Status Ordinal Scale Outcome 5
Fear Score 5
Childhood Myelodysplastic Syndrome
Identifier
Description
azacitidine
Azacitidine
ECOG Performance Status 5
Current Reformed Smoker, Years Unknown
Neck Pain Score 5
Upset Score 5

---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_protocole_versionfinale_site-public_20150720.pdf
2015
Canada
drug information
ECOG Performance Status 5
Agreement Score 5
Fear Score 5
Phase V Trial
Current Reformed Smoker, Years Unknown
Death Related to Adverse Event
Gleason Grade Group 5
Clinical Status Ordinal Scale Outcome 5
Upset Score 5
azacitidine
Thought Score 5
Severity of Symptom Score 5
Azacitidine
Loss of Chromosome 5
Neck Pain Score 5
Illness Intrusiveness Rating 5
Intensity and Distress 5

---
Nous contacter.
11/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.